Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-15
DOI
10.1038/s41388-018-0660-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bootstrapping the out-of-sample predictions for efficient and accurate cross-validation
- (2018) Ioannis Tsamardinos et al. MACHINE LEARNING
- The prognostic value of circulating cell-free DNA in breast cancer
- (2018) Guoqiang Tan et al. MEDICINE
- A Validated Clinical Risk Prediction Model for Lung Cancer in Smokers of All Ages and Exposure Types: A HUNT Study
- (2018) Maria Markaki et al. EBioMedicine
- MatureP: prediction of secreted proteins with exclusive information from their mature regions
- (2017) Georgia Orfanoudaki et al. Scientific Reports
- Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry
- (2016) MAYA KAPPIL et al. ANTICANCER RESEARCH
- SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
- (2016) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Cell-free DNA as a diagnostic marker for cancer: current insights
- (2016) Samanta Salvi et al. OncoTargets and Therapy
- Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer
- (2016) DIMITRIOS MATTHAIOS et al. Oncology Letters
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- GATA3 Expression in Advanced Breast Cancer: Prognostic Value and Organ-Specific Relapse
- (2015) Brandi C. McCleskey et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Measurement of Circulating Cell-Free DNA Levels by a Simple Fluorescent Test in Patients With Breast Cancer
- (2015) Ravit Agassi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A seven-gene CpG-island methylation panel predicts breast cancer progression
- (2015) Yan Li et al. BMC CANCER
- Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
- (2015) Eleonor Olsson et al. EMBO Molecular Medicine
- Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast Cancer
- (2015) Deyuan Fu et al. MEDICINE
- Circulating tumor-derived DNA is shorter than somatic DNA in plasma
- (2015) Florent Mouliere et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
- (2015) Peiyong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
- (2014) Dharanija Madhavan et al. BREAST CANCER RESEARCH AND TREATMENT
- Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
- (2014) Feng Miao et al. DIABETES
- Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
- (2013) K. Pantel et al. CANCER RESEARCH
- The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
- (2013) Yahya Elshimali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients
- (2013) Fatma Trifa et al. TUMOR BIOLOGY
- SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
- (2012) M. Chimonidou et al. CLINICAL CHEMISTRY
- Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix
- (2011) W.F. van der Meide et al. GYNECOLOGIC ONCOLOGY
- Loss of type III transforming growth factor-β receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma
- (2010) S J Cooper et al. ONCOGENE
- Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer
- (2009) M. Kioulafa et al. ANNALS OF ONCOLOGY
- Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer
- (2009) De-Yuan Fu et al. BREAST CANCER RESEARCH AND TREATMENT
- A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis
- (2008) Kirsten Hattermann et al. ANALYTICAL BIOCHEMISTRY
- Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
- (2008) Raquel Catarino et al. DNA AND CELL BIOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now